Navigation

Xeljanz vs. Otezla

Are Xeljanz and Otezla the Same Thing?

Xeljanz (tofacitinib citrate) and Otezla (apremilast) are used to treat different types of arthritis.

Xeljanz is used to treat adults with moderate to severely active rheumatoid arthritis (RA) who have not responded well to methotrexate, or cannot tolerate it.

Otezla is used to treat adult patients with active psoriatic arthritis.

Xeljanz and Otezla belong to different drug classes. Xeljanz is a Janus kinase (JAK) inhibitor and Otezla is a phosphodiesterase 4 (PDE4) inhibitor.

Side effects of Xeljanz and Otezla that are similar include upper respiratory tract infections, headache, diarrhea, and runny or stuffy nose.

Side effects of Xeljanz that are different from Otezla include and cold symptoms such as sore throat.

Side effects of Otezla that are different from Xeljanz include nausea, vomiting, abdominal pain, fatigue, indigestion/heartburn, decreased appetite, insomnia, back pain, frequent bowel movements, depression, bronchitis, tooth abscess, and sinus headache.

Xeljanz may interact with aprepitant, bosentan, conivaptan, haloperidol, imatinib, isoniazid, St. John's wort, ticlopidine, antibiotics, antidepressants, antifungals, hepatitis C medications boceprevir or telaprevir, heart or blood pressure medicines, HIV or AIDS medicines, medications to treat excess stomach acid, medicines to prevent organ transplant rejection, nonsteroidal anti-inflammatory drugs (NSAIDs), other arthritis medications, seizure medications, and steroids.

Otezla may interact with CYP450 inducers (such as rifampin).

What Are Possible Side Effects of Xeljanz?

Side effects of Xeljanz include:

Common side effects of Xeljanz include:

  • upper respiratory tract infections,
  • headache,
  • diarrhea, and
  • cold symptoms such as sore throat, runny or stuffy nose.

Tell your doctor if you experience serious side effects of Xeljanz including:

What Are Possible Side Effects of Otezla?

Common side effects of Otezla include:

  • diarrhea,
  • headache,
  • nausea,
  • upper respiratory tract infection,
  • vomiting,
  • runny or stuffy nose,
  • abdominal pain,
  • fatigue,
  • indigestion/heartburn,
  • decreased appetite,
  • insomnia,
  • back pain,
  • frequent bowel movements,
  • depression,
  • bronchitis,
  • tooth abscess, and
  • sinus headache.

What Is Xeljanz?

Xeljanz (tofacitinib citrate) is a Janus kinase (JAK) inhibitor used to treat adults with moderate to severely active rheumatoid arthritis (RA) who have not responded well to methotrexate, or cannot tolerate it.

What Is Otezla?

Otezla (apremilast) is a phosphodiesterase 4 (PDE4) inhibitor used to treat adult patients with active psoriatic arthritis.

What Drugs Interact With Xeljanz?

Xeljanz may interact with aprepitant, bosentan, conivaptan, haloperidol, imatinib, isoniazid, St. John's wort, ticlopidine, antibiotics, antidepressants, antifungals, hepatitis C medications boceprevir or telaprevir, heart or blood pressure medicines, HIV or AIDS medicines, medications to treat excess stomach acid, medicines to prevent organ transplant rejection, nonsteroidal anti-inflammatory drugs (NSAIDs), other arthritis medications, seizure medications, or steroids. Tell your doctor all medications and supplements you use.

What Drugs Interact With Otezla?

Otezla may interact with CYP450 inducers (such as rifampin).

How Should Xeljanz be Taken?

The recommended dose of Xeljanz is 5 mg twice daily.

How Should Otezla be Taken?

The recommended maintenance dosage is 30 mg twice daily taken orally starting on Day 6, after 5 days of an initial schedule of titration dosing.